183 related articles for article (PubMed ID: 25937299)
1. Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells.
Yao W; Yue P; Zhang G; Owonikoko TK; Khuri FR; Sun SY
Cancer Lett; 2015 Aug; 364(1):70-8. PubMed ID: 25937299
[TBL] [Abstract][Full Text] [Related]
2. Blockade efficacy of MEK/ERK-dependent autophagy enhances PI3K/Akt inhibitor NVP-BKM120's therapeutic effectiveness in lung cancer cells.
Ren H; Guo H; Thakur A; Zhang S; Wang T; Liang Y; Shi P; Gao L; Liu F; Feng J; Chen T; Yang T; Shang D; Liu JJ; Xu F; Chen M
Oncotarget; 2016 Oct; 7(41):67277-67287. PubMed ID: 27572309
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer.
Jin L; Jin MH; Nam AR; Park JE; Bang JH; Oh DY; Bang YJ
Cancer Lett; 2017 Dec; 411():162-170. PubMed ID: 29024814
[TBL] [Abstract][Full Text] [Related]
4. Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.
Schrauwen S; Depreeuw J; Coenegrachts L; Hermans E; Lambrechts D; Amant F
Gynecol Oncol; 2015 Jul; 138(1):165-73. PubMed ID: 25933683
[TBL] [Abstract][Full Text] [Related]
5. Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities.
Talbert EE; Yang J; Mace TA; Farren MR; Farris AB; Young GS; Elnaggar O; Che Z; Timmers CD; Rajasekera P; Maskarinec JM; Bloomston M; Bekaii-Saab T; Guttridge DC; Lesinski GB
Mol Cancer Ther; 2017 Feb; 16(2):344-356. PubMed ID: 27811010
[TBL] [Abstract][Full Text] [Related]
6. A novel hybrid of 3-benzyl coumarin seco-B-ring derivative and phenylsulfonylfuroxan induces apoptosis and autophagy in non-small-cell lung cancer.
Dong M; Ye T; Bi Y; Wang Q; Kuerban K; Li J; Feng M; Wang K; Chen Y; Ye L
Phytomedicine; 2019 Jan; 52():79-88. PubMed ID: 30599915
[TBL] [Abstract][Full Text] [Related]
7. Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer.
Toulany M; Iida M; Keinath S; Iyi FF; Mueck K; Fehrenbacher B; Mansour WY; Schaller M; Wheeler DL; Rodemann HP
Oncotarget; 2016 Jul; 7(28):43746-43761. PubMed ID: 27248324
[TBL] [Abstract][Full Text] [Related]
8. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.
Li YC; He SM; He ZX; Li M; Yang Y; Pang JX; Zhang X; Chow K; Zhou Q; Duan W; Zhou ZW; Yang T; Huang GH; Liu A; Qiu JX; Liu JP; Zhou SF
Cancer Lett; 2014 Mar; 344(2):239-59. PubMed ID: 24280585
[TBL] [Abstract][Full Text] [Related]
9. The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib.
Park KS; Oh B; Lee MH; Nam KY; Jin HR; Yang H; Choi J; Kim SW; Lee DH
Cancer Lett; 2016 Mar; 372(1):75-81. PubMed ID: 26723875
[TBL] [Abstract][Full Text] [Related]
10. Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells.
Ko JC; Ciou SC; Jhan JY; Cheng CM; Su YJ; Chuang SM; Lin ST; Chang CC; Lin YW
Mol Cancer Res; 2009 Aug; 7(8):1378-89. PubMed ID: 19671683
[TBL] [Abstract][Full Text] [Related]
11. Ran GTPase induces EMT and enhances invasion in non-small cell lung cancer cells through activation of PI3K-AKT pathway.
Ning J; Liu W; Zhang J; Lang Y; Xu S
Oncol Res; 2013; 21(2):67-72. PubMed ID: 24406042
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of hydrogen‑rich saline alone and in combination with PI3K inhibitor in non‑small cell lung cancer.
Jiang Y; Liu G; Zhang L; Cheng S; Luo C; Liao Y; Guo S
Mol Med Rep; 2018 Aug; 18(2):2182-2190. PubMed ID: 29901139
[TBL] [Abstract][Full Text] [Related]
13. Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway.
Sakakibara K; Tsujioka T; Kida JI; Kurozumi N; Nakahara T; Suemori SI; Kitanaka A; Arao Y; Tohyama K
Int J Hematol; 2019 Aug; 110(2):213-227. PubMed ID: 31129802
[TBL] [Abstract][Full Text] [Related]
14. Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells.
Zhang Q; Zhu H; Xu X; Li L; Tan H; Cai X
Biochem Biophys Res Commun; 2015 Sep; 465(1):64-70. PubMed ID: 26235873
[TBL] [Abstract][Full Text] [Related]
15. A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells.
Lee H; Kim SJ; Jung KH; Son MK; Yan HH; Hong S; Hong SS
Oncol Rep; 2013 Aug; 30(2):863-9. PubMed ID: 23708425
[TBL] [Abstract][Full Text] [Related]
16. Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer.
Ota K; Azuma K; Kawahara A; Hattori S; Iwama E; Tanizaki J; Harada T; Matsumoto K; Takayama K; Takamori S; Kage M; Hoshino T; Nakanishi Y; Okamoto I
Clin Cancer Res; 2015 Sep; 21(17):4014-21. PubMed ID: 26019170
[TBL] [Abstract][Full Text] [Related]
17. Jervine inhibits non-small cell lung cancer (NSCLC) progression by suppressing Hedgehog and AKT signaling via triggering autophagy-regulated apoptosis.
Lei W; Huo Z
Biochem Biophys Res Commun; 2020 Dec; 533(3):397-403. PubMed ID: 32972750
[TBL] [Abstract][Full Text] [Related]
18. Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells.
Lundholm L; Hååg P; Juntti T; Lewensohn R; Viktorsson K
Int J Radiat Biol; 2014 Aug; 90(8):718-26. PubMed ID: 24646078
[TBL] [Abstract][Full Text] [Related]
19. Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway.
Chen M; Du Y; Qui M; Wang M; Chen K; Huang Z; Jiang M; Xiong F; Chen J; Zhou J; Jiang F; Yin L; Tang Y; Ye L; Zhan Z; Duan JΑ; Fu HΑ; Zhang X
Oncol Rep; 2013 Feb; 29(2):430-6. PubMed ID: 23151908
[TBL] [Abstract][Full Text] [Related]
20. Cinnamtannin D1 from Rhododendron formosanum Induces Autophagy via the Inhibition of Akt/mTOR and Activation of ERK1/2 in Non-Small-Cell Lung Carcinoma Cells.
Way TD; Tsai SJ; Wang CM; Jhan YL; Ho CT; Chou CH
J Agric Food Chem; 2015 Dec; 63(48):10407-17. PubMed ID: 26567590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
